For the Media
Dr. Kelly Paulson is a senior hematology/oncology fellow in the Chapuis Lab of Fred Hutch's Clinical Research Division. Her research is focused on the development of combination T cell immunotherapies for Merkel cell carcinoma. Dr. Paulson's research includes the application of cutting-edge technologies to answer relevant biological and clinical questions and the development of effective prognostic tools,
Kelly Paulson - Brief Curriculum Vitae
Appointments, affiliations and researcher interests
Building on positive results with adoptive transfer of T cells targeting specific antigens in HIV and melanoma, the Chapuis Lab is focused on understanding the factors associated with successful therapies so that adoptive T cells therapies can be further optimized to better eliminate tumors.
Program in Immunology
Researchers are learning how to empower a patient’s own immune system to do what it does naturally — fight disease. They continue discovering new ways to give the immune cell army the upper hand against cancer and learning how immune cells respond to disease and how to safely enhance immune responses to better control, cure and potentially prevent cancers and other serious diseases.
Clinical Research Division
Researchers conduct laboratory and patient-oriented research to better understand the mechanisms that drive cancer and other human diseases. Integrating a variety of disciplines, our investigators are continually developing new therapeutic approaches and leading clinical trials that help move discoveries from laboratory to patient. Our pioneering research has saved hundreds of thousands of lives.
At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer with minimal side effects. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first and largest cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Private contributions are essential for enabling Fred Hutch scientists to explore novel research opportunities that lead to important medical breakthroughs. For more information visit fredhutch.org or follow Fred Hutch on Facebook, Twitter or YouTube.